Amarin Corp Plc (AMRN)

[KCSVEN]

I wonder what analyses he did about off label use? We all know about the expensive cost off label and the doctors not wanting to go through hoops to prescribe. I'm sure he spent a ton of time on this analyses.

"omega-3 generics, dietary supplements, and foreseeable competition,” he wrote."

Ummm, What?
1-the population that the label will be for can get the drug cheaper through insurance in the future than they could even by OTC, if you are not able to get it because you don't qualify you may take OTC but nobody eligible for Vascepa would do OTC, they'd get the purified real thing.

2-There are no generics in the main population Vascepa will be prescribed for

3-There is no foreseeable competition

What a loser!